This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Bruker (BRKR) Introduces the D6 PHASER Benchtop XRD Platform
by Zacks Equity Research
Bruker's (BRKR) new D6 PHASER platform is to be used for material analysis and advanced research.
Bruker (BRKR) Launches ENRICH-iST Kits and Novel Workflow
by Zacks Equity Research
Bruker's (BRKR) ENRICH-iST kit is ready to use right out of the box. The workflow is simple to understand and fully automatable.
Bruker (BRKR) Launches timsTOF Ultra Mass Spec and VistaScan
by Zacks Equity Research
Bruker (BRKR) introduces the timsTOF Ultra mass spectrometer and VistaScan software for enhanced dia-PASEF 4D-Proteomics at the 71st ASMS meeting.
Bruker's (BRKR) Latest Workflows to Aid Applied Markets
by Zacks Equity Research
Bruker (BRKR) introduces Novel EVOQ DART-TQ+ for chromatography-free mass spectrometry for applied markets.
Here's Why You Should Retain Bruker (BRKR) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Bruker Corporation (BRKR) based on the strong performances of CALID and BioSpin Group and its raised 2023 outlook.
Bruker's (BRKR) New Buyout to Advance Digital Transformation
by Zacks Equity Research
Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.
Bruker (BRKR) Tops Q1 Earnings Estimates, Raises '23 Outlook
by Zacks Equity Research
Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.
Bruker (BRKR) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of 16.36% and 7.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Bruker (BRKR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for TE Connectivity (TEL) in Q2 Earnings?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal second-quarter results are expected to reflect strength in the Industrial segment. However, weak Communication and Transportation segments might have been concerns.
What to Expect Ahead of Amazon's (AMZN) Q1 Earnings Release?
by Zacks Equity Research
Amazon's (AMZN) first-quarter results are expected to reflect strength across its Prime and cloud businesses and the smart device portfolio amid rising inflationary pressure.
What's in Store for Texas Instruments (TXN) in Q1 Earnings?
by Zacks Equity Research
Texas Instruments' (TXN) first-quarter 2023 results are likely to reflect solid momentum in Embedded Processing segment amid supply-chain woes.
Why Bruker (BRKR) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Alphabet (GOOGL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Alphabet' (GOOGL) first-quarter results are likely to reflect strength across the search and cloud businesses amid weakness in the ad business.
Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Lam Research (LRCX) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Lam Research's (LRCX) Q3 results are expected to reflect gains from the growing adoption of DRAM and NAND amid macro headwinds.
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Bruker Corporation (BRKR) outperforms the industry and the S&P 500 due to impressive quarterly results and segmental prospects.
Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK
by Zacks Equity Research
Bruker (BRKR) extends support to the expansion efforts of the UK Science community by providing 1.2 GHz Avance NMR spectrometers.
Waters (WAT) Down 6.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bruker (BRKR) Q4 Earnings Beat Estimates, Margins Increase
by Zacks Equity Research
Robust performance across most of the geographies and operating segments drove Bruker's (BRKR) Q4 revenues.
Bruker (BRKR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of 2.78% and 5.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Bruker (BRKR)
by Zacks Equity Research
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Skyworks' (SWKS) Q1 Earnings Meet Estimates, Revenues Down Y/Y
by Zacks Equity Research
Skyworks' (SWKS) first-quarter fiscal 2023 results reflect strong automotive, infrastructure, and industrial end-markets as well as the continued global shift to WiFi 6E and 7.
Top 5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
by Nalak Das
Five large-cap companies are set to beat fourth-quarter earnings estimates this week. These are: PRU, OMC, YUM, SLF, and BRKR.
Sonos (SONO) to Report Q1 Earnings: Factors to Consider
by Zacks Equity Research
Sonos' (SONO) Q1 performance is likely to have been affected by global macro weakness, supply-chain constraints and increasing component costs.